Black Rock Inc. Acer Therapeutics Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.75 - $1.14 $19,650 - $29,867	-26,200 Reduced 25.44%	76,772 $70,000
Q1 2023 May 12, 2023	SELL	$0.67 - $3.05 $10,752 - $48,946	-16,048 Reduced 13.48%	102,972 $78,000
Q4 2022 Feb 13, 2023	BUY	$1.13 - $4.15 $219 - $805	194 Added 0.16%	119,020 $298,000
Q3 2022 Nov 14, 2022	SELL	$1.28 - $1.6 $1,637 - $2,046	-1,279 Reduced 1.06%	118,826 $166,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $3.04 $20,307 - $51,877	17,065 Added 16.56%	120,105 $151,000
Q1 2022 May 12, 2022	SELL	$1.98 - $2.98 $2,512 - $3,781	-1,269 Reduced 1.22%	103,040 $300,000
Q4 2021 Feb 10, 2022	BUY	$1.88 - $2.9 $1,325 - $2,044	705 Added 0.68%	104,309 $237,000
Q3 2021 Nov 09, 2021	SELL	$2.3 - $2.86 $1,297 - $1,613	-564 Reduced 0.54%	103,604 $265,000
Q2 2021 Aug 11, 2021	BUY	$2.52 - $3.18 $262,503 - $331,254	104,168 New	104,168 $299,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.